Honest, exam-focused writing from doctors who sat the same paper. Bookmark a post, then practise the topic on the platform.
Highest prevalence in the region at 13.8%, a fifth of moderate-to-severe disease in people who never smoked, and post-TB COPD where only 27% respond to a bronchodilator against 82% in COPD alone. Plus the household biomass advice and the ceiling-of-care decision the guideline asks you to make on admission.
One salbutamol canister a month raises mortality — and it is sold over the counter here. The national guideline's SABA-free switching table, the exacerbation algorithms, the steroid and nebuliser myths, and the guideline's own admission that its central recommendation is an extrapolation.
The SOGP guideline says to load magnesium sulphate before referral, not on arrival. Here are the dilutions, the toxicity signs, the 80 mL/hour fluid limit, why the target is 140–160 systolic and not lower, and the 40% postnatal eclampsia risk that justifies keeping her three days.
The Pakistan Chest Society replaced the outpatient macrolide with doxycycline and named drug-resistant-pathogen risk as the branch point. Here is the new algorithm, the audit that found 39% of empiric therapy off-guideline, and the breakpoint artefact that makes people abandon a drug that still works.
The world's largest burden — and generic drugs that cure it 98% of the time. Why you need neither a biopsy nor a hepatologist, the FIB-4 threshold that replaces both, and the TB drug that quietly wrecks a twelve-week course.
The losses are front-loaded — 70% don't know they have it. The three staged national targets including the one for over-80s, the non-validated monitor problem, and the two practices the guideline explicitly tells you to stop.
Why the screening age is 30 not 45, the RAPID score with its South Asian waist cut-offs, why the national guideline won't diagnose on HbA1c, and the one ADA recommendation excluded because the drug doesn't exist here.
Fluoroquinolones sit at 24% and co-trimoxazole at 27% in Pakistani series. The two oral agents that still work are exactly the two that cannot treat pyelonephritis — and the nitrofurantoin G6PD rule is softer than you were taught.
Giving vitamin K before you have documented a coagulopathy destroys the one test that matters. Why the admission INR is meaningless, who actually needs hospital, and why the child who ate the pellets almost certainly needs nothing.
Blue-green vomit makes the diagnosis. After that it gets hard — six complications in sequence, three reasons methylene blue can fail or harm, and a set of chelation doses nobody has ever proven.
Chuhay mar dawai covers two completely different poisonings. How to tell them apart, why your staff are at risk from the vomit, why it is not organophosphate — and where two credible sources genuinely disagree.
Harpic is 10.5% hydrochloric acid, a normal-looking mouth means nothing, and the emergency investigation is a contrast CT at 3–6 hours — not the endoscopy most of us were taught to book.
Why you don't cut off the tourniquet the patient arrives with, the krait bite that leaves nothing to see, how the 20-minute clotting test fails, and the one dose rule that makes children different from every other drug you give.
Four days of fever and no focus. Why the first question isn't which of the three, the WHO severe-malaria criteria including the vivax rule most people miss, and the testing order that actually protects the patient.
Exposure categories, the one-week intradermal course, and the three immunoglobulin rules WHO changed in 2018 that most references still teach the old way — including why the leftover should never go into a buttock.
Why ceftriaxone fails, what MMIDSP 2022 says to give for each resistance category with doses, and the one test the national guideline says should never be ordered or relied upon.
The WHO warning signs, what counts as severe dengue, and who actually needs admission — including the two Group B criteria most people forget and why the platelet count alone should not decide it.
The complete national schedule — all 6 visits from birth to 15 months, including the switch to measles-rubella, typhoid conjugate vaccine at 9 months, and both IPV doses. Plus how to handle the child who turns up late.
What candidates actually scored to pass — sitting by sitting — and why aiming for 75% in mocks beats chasing the rumour-of-the-week pass mark.
Does CPSP penalise wrong answers? Should you guess? What happens to blank questions? Doctor-verified answers and exam-day strategy.
One book per subject, no exceptions. Our doctor-tested short list — Snell, Guyton, Robbins, Lippincott — with honest tradeoffs and what NOT to use.
What you'll actually pay for the CPSP exam, the no-refund-after-admit-card rule that catches everyone, and the hidden costs (travel, books, Qbanks) nobody mentions until you're 4 weeks out.
The CPSP portal isn't intuitive. Here's the document checklist, the application flow, the most common rejection reasons, and the gotchas that catch every cycle.
There is no 'easier' centre — the paper is identical. But hall conditions, invigilation strictness, and travel logistics genuinely differ. Honest breakdown to help you decide.
Real strategy from candidates who passed first attempt — daily MCQs, mock-exam cadence, recall priorities, and what NOT to do in the final week.
The mnemonics that actually saved us in the exam — cranial nerves, brachial plexus, abdominal aorta branches, foramen ovale contents, and more. Doctor-tested.
Everything covered in the CPSP FCPS Part 1 exam this year — from Anatomy weightage to Behavioural Sciences high-yield areas, with our recommended study order.
10,176 doctor-verified MCQs, 8,236 real exam recalls, mock exams, mnemonics & high-yield notes. PKR 1,000 for 3 months. No auto-renewal.